Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) shot up 11.9% during trading on Monday . The stock traded as high as $54.70 and last traded at $54.34. 143,915 shares changed hands during mid-day trading, a decline of 50% from the average session volume of 288,866 shares. The stock had previously closed at $48.57.
Wall Street Analysts Forecast Growth
ZEPP has been the topic of several recent analyst reports. Wall Street Zen raised Zepp Health to a "hold" rating in a research note on Saturday, August 16th. Weiss Ratings reissued a "sell (d-)" rating on shares of Zepp Health in a research note on Wednesday, October 8th. Finally, Fundamental Research set a $60.23 target price on Zepp Health and gave the company a "buy" rating in a research note on Tuesday, August 26th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Zepp Health currently has an average rating of "Hold" and an average target price of $60.23.
Check Out Our Latest Stock Report on Zepp Health
Zepp Health Price Performance
The firm has a market cap of $783.65 million, a PE ratio of -11.19 and a beta of 1.32. The firm has a fifty day simple moving average of $43.51 and a two-hundred day simple moving average of $18.06. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.78 and a current ratio of 1.10.
About Zepp Health
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.